Previous 10 | Next 10 |
Baron is an asset management firm focused on delivering growth equity investment solutions known for long-term, fundamental, active approach to growth investing. Baron Asset Fund increased 10.03% (Institutional Shares), while the Russell Midcap Growth Index increased 11.07%, and the S...
Selected Recipients of the New “Back to Screening Award for Research Advocacy Excellence” will be Honored at Fight Colorectal Cancer’s “Path to a Cure” Event in December 2021 Fight Colorectal Cancer (Fight CRC), the nation's leading colorec...
AI Startup Lunit Secures Investment from Guardant Health in a Strategic Funding Round PR Newswire SEOUL , Souh Korea, July 19, 2021 /PRNewswire/ -- Lunit, a leading AI startup in AI-powered cancer solutions, today announced a strategic investment of $26 million...
4X-image/iStock via Getty Images Guardant Health ([[GH]] -0.1%) has made a $26M investment in Lunit, a South Korea-based artificial intelligence-powered cancer solutions company. The investment also includes a collaboration between the two companies. Guardant provides diagnostic tests to help...
ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Providing more formalized structure around the Strategy...
ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Providing more formalized structure around the Strategy...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the second quarter 2021 after market close on Thursday, August 5, 2021. Company management will be webcasting a corresponding conference call beginning at 1:30 ...
Philippe Laffont’s 13F portfolio value decreased from $26.73B to $18.24B this quarter. Coatue Management increased Snowflake, Amazon.com, XPeng, and Li Auto while decreasing Walt Disney, Tesla, Square, and Peloton Interactive. The largest three positions are DoorDash, Snowf...
Sundry Photography/iStock Editorial via Getty Images Labcorp ([[LH]] +0.8%) has launched therascreen KRAS PCR Mutation Analysis, a companion diagnostic to be used with Amgen's ([[AMGN]] +1.3%) non-small cell lung cancer ("NSCLC") treatment Lumakras (sotorasib). Lumacras was approved in M...
Natera (NASDAQ: NTRA) has quietly grown its market cap by more than 875% in the past five years, trouncing the 103% gains of the S&P 500 over that time frame. The $10.25 billion med-tech company, which honed its diagnostics craft on non-invasive blood testing to screen for fetal...
News, Short Squeeze, Breakout and More Instantly...
Shield is first blood test approved by FDA as a primary screening option for colorectal cancer and that meets performance requirements for Medicare coverage Blood test offers easy, convenient and pleasant screening option with potential for improving colorectal cancer screening rates ...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the second quarter 2024 after market close on Wednesday, August 7, 2024. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Ti...
Running on Guardant Infinity™ smart liquid biopsy platform, new Guardant360 test covers over 10 times more genes, including all guideline-recommended genomic biomarkers across advanced solid tumors, and quantifies tumor burden with 10 times higher sensitivity Upgraded test covered ...